BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11020566)

  • 1. High-dose-rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: the 10-year M. D. Anderson cancer center experience.
    Kelly JF; Delclos ME; Morice RC; Huaringa A; Allen PK; Komaki R
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):697-702. PubMed ID: 11020566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative high-dose-rate endobronchial brachytherapy for recurrent carcinoma: the University of Louisville experience.
    Guarnaschelli JN; Jose BO
    J Palliat Med; 2010 Aug; 13(8):981-9. PubMed ID: 20666622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose rate afterloading intraluminal brachytherapy in malignant airway obstruction of lung cancer.
    Chang LF; Horvath J; Peyton W; Ling SS
    Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):589-96. PubMed ID: 7509330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions.
    Delclos ME; Komaki R; Morice RC; Allen PK; Davis M; Garden A
    Radiology; 1996 Oct; 201(1):279-82. PubMed ID: 8816560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endobronchial brachytherapy for symptom palliation in non-small cell lung cancer--analysis of symptom response, endoscopic improvement and quality of life.
    Mallick I; Sharma SC; Behera D
    Lung Cancer; 2007 Mar; 55(3):313-8. PubMed ID: 17157949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose-rate intraluminal irradiation in bronchogenic carcinoma. Technique and results.
    Nori D; Allison R; Kaplan B; Samala E; Osian A; Karbowitz S
    Chest; 1993 Oct; 104(4):1006-11. PubMed ID: 7691481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer.
    Celebioglu B; Gurkan OU; Erdogan S; Savas I; Köse K; Kurtman C; Gonullu U
    Jpn J Clin Oncol; 2002 Nov; 32(11):443-8. PubMed ID: 12499415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of dose and fractionation of endobronchial brachytherapy with or without external radiation in the palliative management of non-small cell lung cancer: a prospective randomized study.
    Mallick I; Sharma SC; Behera D; Ghoshal S; Oinam AS
    J Cancer Res Ther; 2006; 2(3):119-25. PubMed ID: 17998689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose rate brachytherapy for the local control of endobronchial carcinoma following external irradiation.
    Hernandez P; Gursahaney A; Roman T; Schwartzman K; Donath D; Cosio MG; Levy RD
    Thorax; 1996 Apr; 51(4):354-8. PubMed ID: 8733484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose rate endobronchial brachytherapy in the management of primary and recurrent bronchogenic malignancies.
    Gustafson G; Vicini F; Freedman L; Johnston E; Edmundson G; Sherman S; Pursel S; Komic M; Chen P; Borrego JC
    Cancer; 1995 May; 75(9):2345-50. PubMed ID: 7712446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irriadiated lung cancer.
    Kubaszewska M; Skowronek J; Chicheł A; Kanikowski M
    Neoplasma; 2008; 55(3):239-45. PubMed ID: 18348661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractionated intraluminal HDR 192Ir brachytherapy as palliative treatment in patients with endobronchial metastases from non-bronchogenic primaries.
    Stranzl H; Gabor S; Mayer R; Prettenhofer U; Wurzinger G; Hackl A
    Strahlenther Onkol; 2002 Aug; 178(8):442-5. PubMed ID: 12240550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose rate endobronchial brachytherapy in combination with external beam radiotherapy for stage III non-small cell lung cancer.
    Anacak Y; Mogulkoc N; Ozkok S; Goksel T; Haydaroglu A; Bayindir U
    Lung Cancer; 2001 Nov; 34(2):253-9. PubMed ID: 11679184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients.
    Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y
    Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary radiotherapy with endobronchial high-dose-rate brachytherapy boost for inoperable lung cancer: long-term results.
    Rochet N; Hauswald H; Stoiber EM; Hensley FW; Becker HD; Debus J; Lindel K
    Tumori; 2013; 99(2):183-90. PubMed ID: 23748812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of endobronchial brachytherapy: A curative treatment?
    Hennequin C; Bleichner O; Trédaniel J; Quero L; Sergent G; Zalcman G; Maylin C
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):425-30. PubMed ID: 17084547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose endobronchial irradiation in recurrent bronchogenic carcinoma.
    Gauwitz M; Ellerbroek N; Komaki R; Putnam JB; Ryan MB; DeCaro L; Davis M; Cundiff J
    Int J Radiat Oncol Biol Phys; 1992; 23(2):397-400. PubMed ID: 1587762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endobronchial brachytherapy and external-beam radiotherapy in patients with endobronchial obstruction and extrabronchial extension.
    Gejerman G; Mullokandov EA; Bagiella E; Blaivas A; Beitler JJ
    Brachytherapy; 2002; 1(4):204-10. PubMed ID: 15062168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose-rate brachytherapy in symptom palliation due to malignant endobronchial obstruction: a quantitative assessment.
    de Aquino Gorayeb MM; Gregório MG; de Oliveira EQ; Aisen S; Carvalho Hde A
    Brachytherapy; 2013; 12(5):471-8. PubMed ID: 23541114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local determinants of response to endobronchial high-dose rate brachytherapy in bronchogenic carcinoma.
    Ofiara L; Roman T; Schwartzman K; Levy RD
    Chest; 1997 Oct; 112(4):946-53. PubMed ID: 9377957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.